if you use the model to estimate the 2011 objective KSS on a cohort of 100 patients, a patient with an original objective KSS of 88 will have an estimated objective KSS between 79 and 97 points. On the other hand, if you calculate an average original objective KSS of 88 for all 100 patients, the estimated average 2011 objective KSS will be 88 for the group. The predictive model accurately estimated the 2011 function KSS within 0.14 points on the 1000-point 2011 function KSS at the cohort level. At the patient level, the 2011 function KSS was also estimated within 8.8 points of the actual 2011 function KSS. However, 43% of the estimated function scores were greater than 10 points of the actual 2011 function KSS. Conclusions Clinicians and researchers can input their original KSS with demographic data into these equations to estimate the 2011 KSS objective and function scores. The small prediction error of 0.22 points that we calculated indicates that these models can be used to estimate the 2011 objective and function KSS at the aggregated cohort level. Although the average error score was within 10 points at the individual patient level, there was a high percentage of large errors resulting from outliers in the data set. These outliers seemed to be related to patients with excellent range of motion who had substantial pain and limited function or patients who have poor range of motion with excellent function and little pain. This may be inherent with the KSS or with the study sample. Nevertheless, one must use caution when estimating at the patient level. Additionally, the accuracy of the prediction scores decreases if any of the demographic variables included in this study are not available.
Introduction
During the past few decades, several disease-specific measures have been used to evaluate outcomes after TKA and there has been wide variation in the reporting of these measures [14, 15, 18] . Such variation introduces challenges in comparing published studies, which can complicate clinical decision-making, research study design, and policy decisions. Riddle et al. [14] conducted a meta-analysis to determine the extent of the variation in the use of such measurement tools implemented in randomized clinical trials [14] . The findings indicate that the Knee Society Score (KSS) instrument is one of the most commonly reported outcome measures for knee arthroplasty [14] . Therefore, it is important to have the methodology and ability to use historical and longitudinal clinical data obtained using the original KSS while transitioning to the 2011 KSS.
The KSS was initially developed by the Knee Society in 1989 and further modified in 1993 [6] . Based on a panel of Knee Society surgical and clinical experts, the KSS was designed to have an objective knee score to evaluate the knee and a subjective patient function score. Having two separate scores avoids issues of degrading scores solely based on declining function resulting from the natural aging process. The objective knee score includes three main constructs: pain, knee stability, and ROM [6] . Of the maximum 100 points, a possible 50 points are assigned to pain, 25 points to stability, and 25 points for ROM with deductions for deformity and malalignment of the native joint and knee arthroplasty [6] . A well-aligned knee with no pain, 125°of motion, and good AP and mediolateral instability will achieve a KSS of 100 points [6] . The maximum function score is also 100 points and consists of patient-reported outcomes that measure walking distance (50 points) and the ability to ascend and descend stairs (50 points) with deductions for the use of assistive devices such as canes or walkers [6] .
In 2009, the Knee Society Scoring Committee (KSSC) was formed as a multidisciplinary team of arthroplasty surgeons who were Knee Society members as well as epidemiologists and statisticians. Over a 3-year period, the KSSC developed and tested this 2011 KSS system using scientific, psychometric, and validation methodologies, which has been described by Noble et al. in great detail [9, 16] . The 2011 KSS expands on the original KSS and remains both provider-and patient-derived. The 2011 KSS includes an expanded functional component as well as new domains of patient satisfaction and patient expectations [10, 16] . Furthermore, there are minor changes in existing domains of pain, alignment, and stability. In addition to changes in the specific items, the point allocations are also different between the original and the 2011 KSS [6, 16] .
A method to convert original KSS scores to 2011 KSS score has not been developed. As such, it is difficult to evaluate longitudinal clinical outcomes of TKA with the two similar, yet meaningfully different rating systems. The 2011 KSS instrument includes domains that are not covered in the original KSS, which presents a challenge to overcome without an acceptable crosswalk, or prediction, regression model. On the other hand, both versions of the KSS conceptually measure the constructs of pain, function, ROM, alignment, and stability. Given this conceptual similarity, we hypothesized that the regression models would crosswalk to relatively precise predictions, particularly with the addition of data that captured a broader clinical picture to improve the models' ability to estimate the 2011 KSS from the original KSS [9] . The specific aim of this study was to develop a regression equation that precisely converts the original KSS to the 2011 KSS to enable users to evaluate longitudinal outcomes after transitioning from the original KSS to the 2011 KSS.
Patients and Methods
After institutional review board approval, preoperative and postoperative patients undergoing knee arthroplasty from eight high-volume orthopaedic clinics were recruited and enrolled in this study. In our multicenter, cross-sectional, nonrandomized study, a convenience sample of 828 patients undergoing primary TKA provided informed consent. Thirteen patients failed to complete all required forms and were excluded from subsequent analyses (Fig. 1) . The final study cohort includes 815 study patients who completed the original KSS and 2011 KSS. Study patients were surveyed either pre-or postoperatively. Because it was critical to have a large variation in possible KSS and we were not interested in the change from pre-to postoperative, we did not collect pre-and post-data on the same patient. Additionally, patient gender, age, body mass index (BMI), and patient ethnicity were recorded. Data were entered and managed using the REDCap (Research Electronic Data Capture) data management system [5] , which allowed for a multimodal data-capturing plan. In other words, providers and patients could collect data on paper or enter it directly into the system.
Study Sample Characteristics
Of the 815 study patients, 476 (58%) were female and 339 (42%) were male at an average age of 67 years (SD 9.4) ( Table 1 with a total of 84% at greater than 2-year followup assumed to be fully recovered.
Development of Prediction Models
As noted, the key objective was to develop regression models that allow for the prediction, or crosswalk, of the original KSS to the 2011 KSS. The independent variables for the regression models were selected using the components of the original KSS as well as patient demographic variables (age, race/ethnicity, BMI, and gender) and timing/surgical status (pre-versus postoperative) based on clinical knowledge. The distribution of the data (functional form) for each numeric independent variable was tested using a multivariable fractional polynomial (MFP) model. Additionally, the significance of each interaction term was tested for inclusion using MFP to determine whether there was a statistically significant impact of the independent variables on the estimated 2011 objective and function KSS. The MFP results indicated that each numeric independent variable followed a linear form and there were no interaction terms that had a significant effect on the 2011 KSS. Therefore, no squared or higher-order (nonlinear forms) terms or interaction terms were included in the regression models.
We also assessed the functional form, or distribution, of the dependent variables (2011 objective and function KSS) using the method proposed by Manning and Mullahy [6] . Based on the Manning and Mullahy method [6] , the logscale residuals were evaluated for the amount of kurtosis (skewness). The coefficient of kurtosis was [ 3, which indicated that the distribution of both dependent variables (2011 objective and function KSS) had heavy-tailed logscale residuals. Therefore, we log-transformed the 2011 KS objective and function KSS. Finally, one generalized estimating equation regression model was analyzed for each of the dependent variables.
Predictive performance of the models was assessed using 10-fold crossvalidation. Essentially, 10 different, equally sized data sets were randomly constructed from our data and the error between the predicted 2011 KSS and the actual KSS was measured for each data set. These error measures were based on standard predictive performance criteria, known as forecasting errors, which measure the amount of error that exists between the actual (observed) 2011 KSS and the estimated 2011 KSS.
We included the following forecasting errors: mean absolute error (MAE), mean error (ME), and proportion of observations with errors of more than 10 points relative to the minimal clinically important difference (MCID). Although there is no MCID defined in the literature for the 2011 KSS, we estimated an MCID of 10 points ( 1 .
2 of the calculated SD [3, [11] [12] [13] ) using these data. These criteria are all negatively oriented in that lower values are better and reflect less error. The MAE is the average absolute error, meaning it quantifies the absolute difference between the actual score and the predicted score, or estimated score, at the individual patient level without regard for sign (ie, negative or positive number). The ME represents the average error when all of the error scores at the patient level are summed up and averaged across the study sample or cohort. Therefore, the ME is the difference between the actual score and the estimated score at the cohort level. Finally, we calculated the proportion of observations with absolute prediction errors for each model. We established a priori that the MAE would be the primary criterion used to recommend whether the models were appropriate to use to estimate 2011 KSS at the individual patient level. Moreover, we defined an MAE of 10 points (based on our estimated MCID of 10 points) as the cutoff for the acceptability of applying the model at the patient level. Predictive accuracy of the models was also evaluated using Bland-Altman plots, which provide a graphic illustration of the agreement between the observed KSS and the estimated KSS (Figs. 2, 3) . 
Example Case 3
A 64-year-old white woman is seen preoperatively. Her BMI is 27.47 kg/m 2 . Her original objective KSS is 0, her original pain score is 30, her original ROM score is 24 (ROM = 115°), and her original function score is 60. When completing the 2011 KSS, her actual objective score is 29 points. Our crosswalk model predicted her 2011 objective KSS to be 44 points (15-point difference). When completing the 2011 KSS, her actual function score was 58 points. Our crosswalk model predicted her 2011 function score to be 48 points (10-point difference).
Detailed Analysis
The regression model developed to estimate, or predict, the 2011 objective KSS fit the data fairly well with a pseudo R 2 of 0.60, which means that the model explained 60% of the variability of the estimated 2011 objective KSS. This model that estimated the 2011 objective KSS was more accurate at the aggregate, or cohort level, than it was estimating at the individual patient level. On average, at the cohort level, the model estimated the 2011 objective score within 0.22 points (ME = 0. The wide misses, with greater than 35% of the observations that have estimated scores that are not within 10 points of the actual scores, seem to occur with patients who had incongruent ROM with other Knee Society subscores. In other words, patients who had excellent ROM but poor scores on other aspects of the KSS such as alignment, pain, and function were prone to an inaccurate estimate of the 2011 objective KSS. Similarly, the estimated 2011 objective KSS was inaccurate for patients with poor ROM and good scores on other subscores.
Discussion
As a commonly used outcome measure in TKA studies, the new 2011 KSS was a welcome revision with added functionality compared with the original KSS developed in 1989. However, researchers struggled with how to incorporate the new 2011 KSS when considering years of data collected earlier using the original KSS. The purpose of this study was to develop a regression model that can be used to crosswalk the original KSS to the 2011 KSS to enable users to evaluate longitudinal outcomes after transitioning from the original KSS to the 2011 KSS. We developed one model to estimate the 2011 objective KSS and one model to estimate the 2011 function KSS.
The limitation of the study is inherent to the methodology. In a review of crosswalk studies and methodology, Mortimer and Segal [8] addressed the methodological and conceptual concerns with regression crosswalk methodology and found large variation in the explanatory power of regression models. A broad overview of study results indicates that the explanatory power of the regression models is lower when converting scores with disparate constructs and measurement scales [6] . However, both versions of the KSS conceptually measure the constructs of pain, function, ROM, alignment, and stability. The similarity of pain and function domains allowed us to derive precise estimates of the objective and function subscores with good explanatory power of both models (pseudo R 2 of 0.60 for objective and 0.68 for function). However, the additional 2011 KSS domains of patient expectations and patient satisfaction were not included. Therefore, we can only offer crosswalk algorithms for the objective and function subscores. These data also represent private clinics and academic medical centers with a varied patient population. It is thus reasonable to expect that these data and models can be generalized for use with any TKA patient population. Although these models are not perfect, the relatively small prediction errors that we report indicate that the models can be used to estimate the 2011 objective and function KSS at the aggregate, cohort level. At the individual level, the MAEs are less than the MCID, indicating that these models can be applied at the individual level; however, caution should be exercised when using the models in outliers or patients with conflicting subscores (eg, high ROM but poor performance on other subscores). Certainly, if any of the data variables are not accessible, we caution use of either model at the individual patient level as the prediction errors increase without the robust data.
Much of this type of mapping, or crosswalk, methodology has been previously conducted using other outcome measurement tools with the purpose of predicting a generic, preference-based healthy utility measure from a diseasespecific measure or two generic health-related quality-of-life instruments [2, 4, 8] . To our knowledge, there are no equivalent studies in arthroplasty that offer a direct comparison to our results. Although the use of regression models to map, or crosswalk, values from disease-specific health measurement instruments to utilities derived from generic health measurement instruments is increasing, there have been few studies related to osteoarthritis and total joint arthroplasty [1, 4, 8, 9, 17] . Furthermore, the WOMAC is the only disease-specific instrument that has been mapped to predict a preference-based health utility. Grootendorst et al. [3] developed a model that robustly converts the WOMAC to the Health Utilities Index 3 (HUI3) within 20 points in patients undergoing TKA and Marshall et al. [7] validated that model in patients undergoing THA with equally good results. Similarly, Barton et al. [1] In conclusion, the results of this study offer a fairly precise algorithm that can crosswalk the original KSS objective scores and KSS function scores to the 2011 KSS objective and function scores. The low predictive errors indicate that these algorithms can be used at the individual patient level. However, if any of the variables in the regression model that we developed and are proposing are missing in the original score, our recommendation is to only use the scores at the aggregate level (ie, average values for a large cohort). We have made available the regression models and coefficients that the user can select and use based on their available data. Furthermore, a Microsoft Office Excel program is provided (Appendix 1: Score Estimation Worksheet [Supplemental materials are available with the online version of CORR1.]) that clinicians and researchers can input their historical KSS with demographic data into to crosswalk to the 2011 KSS objective and function scores.
